Alzex Neuropharma Inc. (TRRI)
OTCMKTS
· Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
At close: Feb 6, 2026
Alzex Neuropharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | 2006 |
|---|---|---|---|---|---|---|
Period Ending | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 | Dec '09 Dec 31, 2009 | Dec '08 Dec 31, 2008 | Dec '07 Dec 31, 2007 | 2006 |
| Cash & Equivalents | 0.11 | 0.05 | 0 | 0.05 | 0.1 | Upgrade
|
| Short-Term Investments | - | - | - | - | 0 | Upgrade
|
| Cash & Short-Term Investments | 0.11 | 0.05 | 0 | 0.05 | 0.1 | Upgrade
|
| Cash Growth | 108.46% | 1145.78% | -90.88% | -53.14% | -31.23% | Upgrade
|
| Accounts Receivable | 0.17 | 0.35 | 0.38 | 0.49 | 0.65 | Upgrade
|
| Receivables | 0.17 | 0.35 | 0.38 | 0.49 | 0.68 | Upgrade
|
| Other Current Assets | 0.01 | 0.02 | 0 | 0.02 | 0.01 | Upgrade
|
| Total Current Assets | 0.29 | 0.42 | 0.38 | 0.56 | 0.8 | Upgrade
|
| Property, Plant & Equipment | 0 | 0.01 | 0.02 | 0.03 | 0.02 | Upgrade
|
| Goodwill | 1.35 | 1.35 | 1.35 | 1 | 1.35 | Upgrade
|
| Other Intangible Assets | 0.25 | 0.3 | 0.36 | 0.43 | 0.06 | Upgrade
|
| Other Long-Term Assets | - | 0.23 | 0.06 | 0.07 | - | Upgrade
|
| Total Assets | 1.9 | 2.31 | 2.18 | 2.09 | 2.22 | Upgrade
|
| Accounts Payable | 0.08 | 0.08 | 0.11 | 0.02 | 0.01 | Upgrade
|
| Accrued Expenses | 0.11 | 0.12 | 0 | 0.14 | 0.34 | Upgrade
|
| Other Current Liabilities | 0.02 | 0.01 | 0.03 | 0.21 | - | Upgrade
|
| Total Current Liabilities | 0.2 | 0.22 | 0.14 | 0.37 | 0.35 | Upgrade
|
| Long-Term Debt | 0.62 | 0.84 | 1.32 | 1.39 | 1.92 | Upgrade
|
| Other Long-Term Liabilities | 0.03 | 0.05 | 0.09 | - | - | Upgrade
|
| Total Liabilities | 0.85 | 1.11 | 1.56 | 1.76 | 2.27 | Upgrade
|
| Common Stock | 0.71 | 1.2 | 0.25 | 0.09 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 0.03 | - | 0.09 | 0.94 | 0.04 | Upgrade
|
| Retained Earnings | -0.09 | - | -0.2 | - | -0.16 | Upgrade
|
| Comprehensive Income & Other | 0.39 | - | 0.46 | -0.71 | - | Upgrade
|
| Total Common Equity | 1.05 | 1.2 | 0.61 | 0.32 | -0.1 | Upgrade
|
| Shareholders' Equity | 1.05 | 1.2 | 0.62 | 0.33 | -0.05 | Upgrade
|
| Total Liabilities & Equity | 1.9 | 2.31 | 2.18 | 2.09 | 2.22 | Upgrade
|
| Total Debt | 0.62 | 0.84 | 1.32 | 1.39 | 1.92 | Upgrade
|
| Net Cash (Debt) | -0.51 | -0.78 | -1.32 | -1.34 | -1.82 | Upgrade
|
| Working Capital | 0.09 | 0.2 | 0.24 | 0.19 | 0.45 | Upgrade
|
| Tangible Book Value | -0.56 | -0.45 | -1.1 | -1.11 | -1.51 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.